• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于单细胞测序分析的透明细胞肾细胞癌免疫亚型相关预后特征的鉴定

Identification of an immune subtype-related prognostic signature of clear cell renal cell carcinoma based on single-cell sequencing analysis.

作者信息

Fan Zongyao, Xu Hewei, Ge Qingyu, Li Weilong, Zhang Junjie, Pu Yannan, Chen Zhengsen, Zhang Sicong, Xue Jun, Shen Baixin, Ding Liucheng, Wei Zhongqing

机构信息

Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Department of Urology, The Second Clinical Medical College of Nanjing Medical University, Nanjing, China.

出版信息

Front Oncol. 2023 Mar 22;13:1067987. doi: 10.3389/fonc.2023.1067987. eCollection 2023.

DOI:10.3389/fonc.2023.1067987
PMID:37035172
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10073649/
Abstract

BACKGROUND

There is growing evidence that immune cells are strongly associated with the prognosis and treatment of clear cell renal cell carcinoma (ccRCC). Our aim is to construct an immune subtype-related model to predict the prognosis of ccRCC patients and to provide guidance for finding appropriate treatment strategies.

METHODS

Based on single-cell analysis of the GSE152938 dataset from the GEO database, we defined the immune subtype-related genes in ccRCC. Immediately afterwards, we used Cox regression and Lasso regression to build a prognostic model based on TCGA database. Then, we carried out a series of evaluation analyses around the model. Finally, we proved the role of VMP1 in ccRCC by cellular assays.

RESULT

Initially, based on TCGA ccRCC patient data and GEO ccRCC single-cell data, we successfully constructed a prognostic model consisting of five genes. Survival analysis showed that the higher the risk score, the worse the prognosis. We also found that the model had high predictive accuracy for patient prognosis through ROC analysis. In addition, we found that patients in the high-risk group had stronger immune cell infiltration and higher levels of immune checkpoint gene expression. Finally, cellular experiments demonstrated that when the VMP1 gene was knocked down, 786-O cells showed reduced proliferation, migration, and invasion ability and increased levels of apoptosis.

CONCLUSION

Our study can provide a reference for the diagnosis and treatment of patients with ccRCC.

摘要

背景

越来越多的证据表明免疫细胞与透明细胞肾细胞癌(ccRCC)的预后和治疗密切相关。我们的目的是构建一个与免疫亚型相关的模型,以预测ccRCC患者的预后,并为寻找合适的治疗策略提供指导。

方法

基于来自GEO数据库的GSE152938数据集的单细胞分析,我们定义了ccRCC中与免疫亚型相关的基因。随后,我们使用Cox回归和Lasso回归基于TCGA数据库构建了一个预后模型。然后,我们围绕该模型进行了一系列评估分析。最后,我们通过细胞实验证明了VMP1在ccRCC中的作用。

结果

最初,基于TCGA ccRCC患者数据和GEO ccRCC单细胞数据,我们成功构建了一个由五个基因组成的预后模型。生存分析表明,风险评分越高,预后越差。我们还通过ROC分析发现该模型对患者预后具有较高的预测准确性。此外,我们发现高危组患者的免疫细胞浸润更强,免疫检查点基因表达水平更高。最后,细胞实验表明,当VMP1基因被敲低时,786-O细胞的增殖、迁移和侵袭能力降低,凋亡水平升高。

结论

我们的研究可为ccRCC患者的诊断和治疗提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/87f831b28aaf/fonc-13-1067987-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/05cc0e1b9562/fonc-13-1067987-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/7e6c28a07dc7/fonc-13-1067987-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/bde4089e857c/fonc-13-1067987-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/4a23f51f89a7/fonc-13-1067987-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/0367b8295b8d/fonc-13-1067987-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/47473f992e00/fonc-13-1067987-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/d991bc59d721/fonc-13-1067987-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/240dbcd1c9b0/fonc-13-1067987-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/a0bbc0f5d1fa/fonc-13-1067987-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/87f831b28aaf/fonc-13-1067987-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/05cc0e1b9562/fonc-13-1067987-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/7e6c28a07dc7/fonc-13-1067987-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/bde4089e857c/fonc-13-1067987-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/4a23f51f89a7/fonc-13-1067987-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/0367b8295b8d/fonc-13-1067987-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/47473f992e00/fonc-13-1067987-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/d991bc59d721/fonc-13-1067987-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/240dbcd1c9b0/fonc-13-1067987-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/a0bbc0f5d1fa/fonc-13-1067987-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef2/10073649/87f831b28aaf/fonc-13-1067987-g010.jpg

相似文献

1
Identification of an immune subtype-related prognostic signature of clear cell renal cell carcinoma based on single-cell sequencing analysis.基于单细胞测序分析的透明细胞肾细胞癌免疫亚型相关预后特征的鉴定
Front Oncol. 2023 Mar 22;13:1067987. doi: 10.3389/fonc.2023.1067987. eCollection 2023.
2
Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma.与肿瘤免疫浸润相关的铁死亡相关长链非编码RNA特征分析及在肾透明细胞癌中的实验验证
Int J Gen Med. 2022 Mar 19;15:3215-3235. doi: 10.2147/IJGM.S354682. eCollection 2022.
3
Development and implementation of a prognostic model for clear cell renal cell carcinoma based on heterogeneous TLR4 expression.基于异质性TLR4表达的透明细胞肾细胞癌预后模型的开发与应用
Heliyon. 2024 Feb 12;10(4):e25571. doi: 10.1016/j.heliyon.2024.e25571. eCollection 2024 Feb 29.
4
Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.基于铁死亡相关基因特征预测透明细胞肾细胞癌患者的总生存期。
World J Surg Oncol. 2022 Apr 14;20(1):120. doi: 10.1186/s12957-022-02555-9.
5
A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.基于免疫异质性的放射组学生物标志物用于肾透明细胞癌的无创预后评估。
Front Immunol. 2022 Sep 13;13:956679. doi: 10.3389/fimmu.2022.956679. eCollection 2022.
6
Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.用于预测透明细胞肾细胞癌患者生存的自噬相关预后风险特征的构建与验证
Front Oncol. 2020 May 5;10:707. doi: 10.3389/fonc.2020.00707. eCollection 2020.
7
A novel brown adipocytes-related gene signature predicts and validates prognosis and immune infiltration of clear cell renal cell carcinoma.一种新型棕色脂肪细胞相关基因特征可预测并验证透明细胞肾细胞癌的预后和免疫浸润。
Am J Cancer Res. 2024 Sep 15;14(9):4286-4305. doi: 10.62347/VIQM5219. eCollection 2024.
8
Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.构建具有预后意义的新型免疫相关 lncRNA 对用于肾透明细胞肾细胞癌。
Dis Markers. 2021 Sep 1;2021:8800358. doi: 10.1155/2021/8800358. eCollection 2021.
9
A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.基于免疫基因组学的透明细胞肾细胞癌新型预后模型。
Int Immunopharmacol. 2021 Jan;90:107119. doi: 10.1016/j.intimp.2020.107119. Epub 2020 Nov 24.
10
Identification of a Novel Glycolysis-Related Gene Signature Correlates With the Prognosis and Therapeutic Responses in Patients With Clear Cell Renal Cell Carcinoma.一种与透明细胞肾细胞癌患者预后和治疗反应相关的新型糖酵解相关基因特征的鉴定
Front Oncol. 2021 Mar 17;11:633950. doi: 10.3389/fonc.2021.633950. eCollection 2021.

本文引用的文献

1
The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma.早期肺腺癌中 B 细胞和浆细胞的单细胞免疫基因组图谱。
Cancer Discov. 2022 Nov 2;12(11):2626-2645. doi: 10.1158/2159-8290.CD-21-1658.
2
Plasma CD27, a Surrogate of the Intratumoral CD27-CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma.血浆 CD27,肿瘤内 CD27-CD70 相互作用的替代物,与肾细胞癌的免疫治疗抵抗相关。
Clin Cancer Res. 2022 Nov 14;28(22):4983-4994. doi: 10.1158/1078-0432.CCR-22-0905.
3
Profiling of syngeneic mouse HCC tumor models as a framework to understand anti-PD-1 sensitive tumor microenvironments.
同种小鼠 HCC 肿瘤模型分析作为理解抗 PD-1 敏感肿瘤微环境的框架。
Hepatology. 2023 May 1;77(5):1566-1579. doi: 10.1002/hep.32707. Epub 2023 Apr 17.
4
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update.欧洲泌尿外科学会肾癌指南:2022 年更新版。
Eur Urol. 2022 Oct;82(4):399-410. doi: 10.1016/j.eururo.2022.03.006. Epub 2022 Mar 26.
5
Immune escape mechanism behind resistance to anti-PD-1 therapy in gastrointestinal tract metastasis in malignant melanoma patients with multiple metastases.免疫逃逸机制导致恶性黑色素瘤多发性转移患者抗 PD-1 治疗对胃肠道转移无效。
Cancer Immunol Immunother. 2022 Sep;71(9):2293-2300. doi: 10.1007/s00262-022-03154-z. Epub 2022 Jan 30.
6
T and NK cell abundance defines two distinct subgroups of renal cell carcinoma.T细胞和自然杀伤细胞的丰度定义了肾细胞癌的两个不同亚组。
Oncoimmunology. 2022 Jan 4;11(1):1993042. doi: 10.1080/2162402X.2021.1993042. eCollection 2022.
7
Unravelling glioblastoma heterogeneity by means of single-cell RNA sequencing.通过单细胞 RNA 测序揭示胶质母细胞瘤异质性。
Cancer Lett. 2022 Feb 28;527:66-79. doi: 10.1016/j.canlet.2021.12.008. Epub 2021 Dec 10.
8
IFI30 expression predicts patient prognosis in breast cancer and dictates breast cancer cells proliferation via regulating autophagy.IFI30 表达可预测乳腺癌患者的预后,并通过调节自噬来控制乳腺癌细胞的增殖。
Int J Med Sci. 2021 Jul 25;18(14):3342-3352. doi: 10.7150/ijms.62870. eCollection 2021.
9
VMP1, a novel prognostic biomarker, contributes to glioma development by regulating autophagy.VMP1 通过调控自噬促进胶质瘤发生发展,是一个新的预后生物标志物。
J Neuroinflammation. 2021 Jul 26;18(1):165. doi: 10.1186/s12974-021-02213-z.
10
Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages.单细胞蛋白活性分析鉴定出与复发相关的肾肿瘤巨噬细胞。
Cell. 2021 May 27;184(11):2988-3005.e16. doi: 10.1016/j.cell.2021.04.038. Epub 2021 May 20.